NCT00359879 - Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

377

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Type 2 Diabetes

Interventions

DRUG

exenatide

subcutaneous injection, 5mcg or 10mcg, twice a day (before lunch and dinner)

DRUG

exenatide

subcutaneous injection, 5mcg or 10mcg, twice a day (before breakfast and dinner)

Trial Locations (15)

Research Site, Campinas

Research Site, Curitiba

Research Site, Fortaleza

Research Site, Goiânia

Research Site, Porto Alegre

Research Site, Rio de Janeiro

Research Site, Salvador

Research Site, São José do Rio Preto

Research Site, São Paulo

Research Site, Aguascalientes

Research Site, Guadalajara

Research Site, Monterrey

Research Site, San Luis Potosí City

Research Site, Mérida

Research Site, Mexico City